{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:50:39Z","timestamp":1756572639000,"version":"3.37.3"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>In recent studies, vibration-controlled transient elastography (FibroScan) has been reported as an alternative noninvasive approach for measuring liver steatosis and fibrosis. The present study aimed to investigate the feasibility of FibroScan controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) in the detection of increased arterial stiffness in asymptomatic populations in China.<\/jats:p>\n            <jats:p>A retrospective cohort recruiting 4747 asymptomatic patients with no underlying causes of liver disease and having FibroScan and brachial-ankle pulse wave velocity (baPWV) during wellness check-up was covered. Nonalcoholic fatty liver disease (NAFLD) was defined as a CAP \u2265238\u200adB\/m. NAFLD with significant fibrosis was defined as an LSM \u22657.3 kPa in the presence of NAFLD. Increased arterial stiffness was determined as a BaPWV \u22651.4m\/second.<\/jats:p>\n            <jats:p>Among the 4747 study participants, 1596 subjects (33.6%) suffered from increased arterial stiffness. The prevalence of increased arterial stiffness progressively increased across CAP quartiles and LSM quartiles in NAFLD (23.5%, 30.8%, 38.3%, 43.7%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001 and 33.1%, 36.8%, 40.4%, 48.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001, respectively). After conventional cardiovascular risk factors were adjusted (age, sex, overweight, diabetes mellitus, hypertension, hypercholesterolemia, and current smoking habits), multivariate logistic regression analysis revealed that CAP (odd ratio [OR]\u200a=\u200a1.005; 95% confidence interval [CI]: 1.003\u20131.006; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), NAFLD (OR\u200a=\u200a1.427; 95% CI: 1.212\u20131.681; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), LSM in NAFLD (OR\u200a=\u200a1.073; 95% CI: 1.023\u20131.125; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003), and significant fibrosis in NAFLD (OR\u200a=\u200a1.480; 95% CI: 1.090\u20132.010; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.012) were independently associated with increased arterial stiffness. Furthermore, in a multivariate logistic regression analysis, OR (95% CI) for the maximal vs. the minimal quartile of CAP was 1.602 (1.268\u20132.024), and that of LSM in NAFLD was 1.362 (1.034\u20131.792) after adjustment for the above-mentioned risk factors. Notably, NAFLD and significant fibrosis in NAFLD were significantly correlated only with increased arterial stiffness in subjects without hypertension or diabetes mellitus after adjustment for the above-mentioned risk factors.<\/jats:p>\n            <jats:p>CAP-defined NAFLD and LSM-defined significant fibrosis in NAFLD showed significant and independent relationships with increased arterial stiffness even after adjustment for conventional cardiovascular risk factors, which can be conducive to stratifying relative risk of subjects having undergone screening assessment for cardiovascular disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023360","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T18:14:50Z","timestamp":1606155290000},"page":"e23360","source":"Crossref","is-referenced-by-count":11,"title":["Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China"],"prefix":"10.1097","volume":"99","author":[{"given":"Xin-yan","family":"Yu","sequence":"first","affiliation":[{"name":"Department of General Practice and Health Management Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xiao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ling","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of General Practice and Health Management Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-yan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Practice and Health Management Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-5953","authenticated-orcid":false,"given":"Zhen-ya","family":"Song","sequence":"additional","affiliation":[{"name":"Department of General Practice and Health Management Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"R1-20240523","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20240523","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"R3-20240523","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R4-20240523","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"R5-20240523","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jacc.2013.12.041","article-title":"Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study","volume":"63","author":"van Sloten","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R6-20240523","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1291\/hypres.25.359","article-title":"Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement","volume":"25","author":"Yamashina","year":"2002","journal-title":"Hypertens Res"},{"key":"R7-20240523","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/hr.2010.103","article-title":"Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study, Japan","volume":"33","author":"Turin","year":"2010","journal-title":"Hypertens Res"},{"key":"R8-20240523","first-page":"404","article-title":"Brachial-ankle pulse wave velocity for the prediction of the presence and severity of coronary artery disease","volume":"36","author":"Kim","year":"2014","journal-title":"Clin Exp Hypertens (New York, NY: 1993)"},{"key":"R9-20240523","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1291\/hypres.31.1079","article-title":"The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients","volume":"31","author":"Xu","year":"2008","journal-title":"Hypertens Res"},{"key":"R10-20240523","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"R11-20240523","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R12-20240523","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"R13-20240523","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"R14-20240523","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"R15-20240523","first-page":"i","article-title":"Report of a WHO consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R16-20240523","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by transient elastography","volume":"57","author":"Boursier","year":"2013","journal-title":"Hepatology"},{"key":"R17-20240523","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3748\/wjg.v19.i1.49","article-title":"Performance of liver stiffness measurements by transient elastography in chronic hepatitis","volume":"19","author":"Ferraioli","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R18-20240523","doi-asserted-by":"crossref","first-page":"e0157358","DOI":"10.1371\/journal.pone.0157358","article-title":"Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease","volume":"11","author":"Lee","year":"2016","journal-title":"Plos One"},{"key":"R19-20240523","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1631\/jzus.B1400028","article-title":"Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population","volume":"15","author":"Yu","year":"2014","journal-title":"J Zhejiang Univers Sci B"},{"key":"R20-20240523","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R21-20240523","doi-asserted-by":"crossref","first-page":"e0224942","DOI":"10.1371\/journal.pone.0224942","article-title":"The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women","volume":"14","author":"Fu","year":"2019","journal-title":"Plos One"},{"key":"R22-20240523","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R23-20240523","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-5926-4-10","article-title":"The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis","volume":"4","author":"Poynard","year":"2005","journal-title":"Comp Hepatol"},{"key":"R24-20240523","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"R25-20240523","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R26-20240523","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-20240523","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R28-20240523","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11883-013-0387-8","article-title":"Arterial stiffness as a risk factor for coronary artery disease","volume":"16","author":"Liao","year":"2014","journal-title":"Curr Atherosclerosis Rep"},{"key":"R29-20240523","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrcardio.2017.155","article-title":"Arterial stiffness as a risk factor for clinical hypertension","volume":"15","author":"Safar","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R30-20240523","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/ajh\/hpw036","article-title":"Prediabetes and diabetes are associated with arterial stiffness in older adults: the ARIC Study","volume":"29","author":"Loehr","year":"2016","journal-title":"Am J Hypertens"},{"key":"R31-20240523","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/dc12-1463","article-title":"Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study","volume":"36","author":"Chirinos","year":"2013","journal-title":"Diabetes Care"},{"key":"R32-20240523","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2014.12.023","article-title":"Arterial stiffness in diabetes mellitus","volume":"238","author":"Prenner","year":"2015","journal-title":"Atherosclerosis"},{"key":"R33-20240523","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/dc17-1071","article-title":"Arterial stiffness and incidence of diabetes: a population-based cohort study","volume":"40","author":"Muhammad","year":"2017","journal-title":"Diabetes Care"},{"key":"R34-20240523","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.arr.2014.02.002","article-title":"Arterial stiffness, the brain and cognition: a systematic review","volume":"15","author":"Singer","year":"2014","journal-title":"Ageing Res Rev"},{"key":"R35-20240523","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.dld.2018.04.027","article-title":"Usefulness of controlled attenuation parameter for detecting increased arterial stiffness in general population","volume":"50","author":"Park","year":"2018","journal-title":"Dig Liver Dis"},{"key":"R36-20240523","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2019.02.005","article-title":"Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil","volume":"284","author":"Harada","year":"2019","journal-title":"Atherosclerosis"},{"key":"R37-20240523","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12872-018-0877-2","article-title":"Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Cardiovascular Disorders"},{"key":"R38-20240523","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.numecd.2014.10.002","article-title":"Non-alcoholic fatty liver disease is associated with progression of arterial stiffness","volume":"25","author":"Li","year":"2015","journal-title":"Nutr, Metab Cardiovascular Dis"},{"key":"R39-20240523","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"R40-20240523","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","article-title":"Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"241","author":"Chen","year":"2015","journal-title":"Atherosclerosis"},{"key":"R41-20240523","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MEG.0000000000001471","article-title":"Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease","volume":"32","author":"Bilgin","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R42-20240523","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"New Eng J Med"},{"key":"R43-20240523","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"R44-20240523","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1479164115585009","article-title":"Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes","volume":"12","author":"Chou","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"R45-20240523","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/j.1572-0241.2008.02188.x","article-title":"Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study","volume":"103","author":"McKimmie","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R46-20240523","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.numecd.2012.05.007","article-title":"Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension","volume":"23","author":"Catena","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R47-20240523","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","article-title":"Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update","volume":"21","author":"Athyros","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:18:49Z","timestamp":1716473929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":47,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023360","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}